Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation

被引：44
|
作者：
Ciurea, Stefan O. [1 ]
Sadegi, Barry [2 ]
Wilbur, Andrew [2 ]
Alagiozian-Angelova, Victoria [3 ]
Gaitonde, Sujata [3 ]
Dobogai, Lisa C. [1 ]
Akard, Luke P. [4 ]
Hoffman, Ronald [5 ]
Rondelli, Damiano [1 ]
机构：
[1] Univ Illinois, Hematol Oncol Sect, Coll Med, Div Hematol,Dept Med, Chicago, IL 60612 USA
[2] Univ Illinois, Coll Med, Dept Radiol, Chicago, IL 60612 USA
[3] Univ Illinois, Coll Med, Div Hematopathol, Dept Pathol, Chicago, IL 60612 USA
[4] Indiana Blood & Marrow Transplantat Program, Indianapolis, IN USA
[5] Mt Sinai Sch Med, Hematol Oncol Sect, New York, NY USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2008年 / 141卷 / 01期
关键词：
myeloproliferative disorder; splenomegaly; reduced-intensity conditioning stem cell transplantation; myelofibrosis;
D O I：
10.1111/j.1365-2141.2008.07010.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Changes in spleen size postallogeneic haematopoietic stem cell transplantation (HSCT) in patients with primary myelofibrosis have been poorly characterized. We analysed 10 patients with myelofibrosis and splenomegaly following a reduced-intensity allogeneic HSCT. All patients fully engrafted donor cells including five patients with extensive splenomegaly. Extensive splenomegaly was associated with a prolonged time to neutrophil and platelet recovery. In all 10 patients, a progressive reduction of splenomegaly was documented within 12 months post-transplant and paralleled the reduction of marrow fibrosis. These findings suggest that myelofibrosis patients with extensive splenomegaly may proceed with allogeneic HSCT without prior splenectomy.
引用
收藏
页码：80 / 83
页数：4
相关论文
共 50 条
  • [21] Allogeneic stem cell transplantation with reduced intensity conditioning for patients with adrenoleukodystrophy
    Kato, Koji
    Maemura, Ryo
    Wakamatsu, Manabu
    Yamamori, Ayako
    Hamada, Motoharu
    Kataoka, Shinsuke
    Narita, Atsushi
    Miwata, Shunsuke
    Sekiya, Yuko
    Kawashima, Nozomu
    Suzuki, Kyogo
    Narita, Kotaro
    Doisaki, Sayoko
    Muramatsu, Hideki
    Sakaguchi, Hirotoshi
    Matsumoto, Kimikazu
    Koike, Yuka
    Onodera, Osamu
    Kaga, Makiko
    Shimozawa, Nobuyuki
    Yoshida, Nao
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2019, 18 : 1 - 6
  • [22] Outcome of allogeneic stem cell transplantation in patients with myelofibrosis
    M Ditschkowski
    D W Beelen
    R Trenschel
    M Koldehoff
    A H Elmaagacli
    Bone Marrow Transplantation, 2004, 34 : 807 - 813
  • [23] Outcome of allogeneic stem cell transplantation in patients with myelofibrosis
    Ditschkowski, M
    Beelen, DW
    Trenschel, R
    Koldehoff, M
    Elmaagacli, AH
    BONE MARROW TRANSPLANTATION, 2004, 34 (09) : 807 - 813
  • [24] Reduced Intensity Stem Cell Transplantation for Accelerated Phase Myelofibrosis
    Gagelmann, Nico
    Badbaran, Anita
    Ditschkowski, Markus
    Panagiota, Victoria
    Cassinat, Bruno
    Heuser, Michael
    Thol, Felicitas
    Wolschke, Christine
    Salit, Rachel B.
    Robin, Marie
    Beelen, Dietrich W.
    Scott, Bart L.
    Kroeger, Nicolaus
    BLOOD, 2021, 138
  • [25] Impact of conditioning intensity on outcome in high-risk myelofibrosis undergoing allogeneic stem cell transplantation
    Gagelmann, N.
    Badbaran, A.
    Ditschkowski, M.
    Bogdanov, R.
    Panagiota, V
    Thol, F.
    Robin, M.
    Heuser, M.
    Beelen, D.
    Kroeger, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 58 - 59
  • [26] Recent results of allogeneic stem cell transplantation for myelofibrosis using reduced intensity conditioning - the Swedish experience
    Lenhoff, S.
    Dreimane, A.
    Ejerblad, E.
    Isaksson, C.
    Ljungman, P.
    Brune, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S493 - S494
  • [27] Splenic Irradiation as a Component of a Reduced-Intensity Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Myelofibrosis with Massive Splenomegaly
    Ito, Takeshi
    Akagi, Kentaro
    Kondo, Tadakazu
    Kawabata, Hiroshi
    Ichinohe, Tatsuo
    Takaori-Kondo, Akifumi
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2012, 228 (04): : 295 - 299
  • [28] Allogeneic Stem Cell Transplantation in Myelofibrosis
    Jain, Tania
    Mesa, Ruben A.
    Palmer, Jeanne M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (09) : 1429 - 1436
  • [29] Prognostic Factors of CLL Patients Undergoing Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation in the Immunochemotherapy Era
    Lahoud, Oscar B.
    Hilden, Patrick
    Maloy, Molly A.
    Dahi, Parastoo B.
    Castro-Malaspina, Hugo
    Perales, Miguel-Angel
    Giralt, Sergio A.
    Sauter, Craig S.
    BLOOD, 2016, 128 (22)
  • [30] Prognostic Factors of CLL Patients Undergoing Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation in the Immunochemotherapy Era
    Lahoud, Oscar Boutros
    Hilden, Patrick
    Maloy, Molly
    Dahi, Parastoo
    Castro-Malaspina, Hugo
    Giralt, Sergio A.
    Perales, Miguel-Angel
    Sauter, Craig S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S207 - S208
12345